P-21 Activated Kinases in Liver Disorders

P-21 Activated Kinases in Liver Disorders

The p21 Activated Kinases (PAKs) are serine threonine kinases and play important roles in many biological processes, including cell growth, survival, cytoskeletal organization, migration, and morphology. Recently, PAKs have emerged in the process of liver disorders, including liver cancer, hepatic i...

Full description

Bibliographic Details
Main Authors:	Xun Qiu, Hanzhi Xu, Kai Wang, Fengqiang Gao, Xiao Xu, Hong He
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Cancers
Subjects:	p21 Activated Kinase liver cancer hepatitis liver fibrosis hepatic ischemia-reperfusion injury small molecular inhibitors
Online Access:	https://www.mdpi.com/2072-6694/15/2/551

Similar Items

The effects of silymarin plus glutathione on the prevention of liver ischemia-reperfusion injury
by: Dilara Aliyeva, et al.
Published: (2022-12-01)

The Role of Hydrogen Sulfide Regulation of Autophagy in Liver Disorders
by: Xueqin Lu, et al.
Published: (2022-04-01)

Effects of remote ischemic preconditioning in hepatectomy: a systematic review and meta-analysis
by: Chun Tian, et al.
Published: (2024-03-01)

Effects of Exosomes Derived from Adipose-Derived Mesenchymal Stem Cells on Pyroptosis and Regeneration of Injured Liver
by: Chenxi Piao, et al.
Published: (2022-10-01)

Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death
by: Shen-ping Tang, et al.
Published: (2022-04-01)

Properdin inhibition ameliorates hepatic ischemia/reperfusion injury without interfering with liver regeneration in mice
by: Jiro Kusakabe, et al.
Published: (2023-08-01)

The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders
by: Xueqin Lu, et al.
Published: (2022-03-01)

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
by: Mauro Viganò, et al.
Published: (2023-03-01)

Hepatoprotection of a Standardized Extract of Cultured <i>Lentinula edodes</i> Mycelia against Liver Injury Induced by Ischemia-Reperfusion and Partial Hepatectomy
by: Richi Nakatake, et al.
Published: (2024-01-01)

Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver
by: Saant Al Mogrampi, et al.
Published: (2023-02-01)

MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury
by: Yu B, et al.
Published: (2023-03-01)

Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
by: Cheng Zhengyuan, et al.
Published: (2023-12-01)

Association between high-sensitivity-CRP and liver elastography and cardiac ischemic diseases in patients with fatty liver
by: Morteza Nayebi, et al.
Published: (2022-01-01)

Editorial: Pathophysiology and pharmacological treatments associated with liver failures
by: Chandana B. Herath, et al.
Published: (2024-04-01)

Increased oxidative stress caused by impaired mitophagy aggravated liver ischemia and reperfusion injury in diabetic mice
by: Kong Zhijun, et al.
Published: (2023-01-01)

The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases
by: Bihan Liu, et al.
Published: (2022-12-01)

Liver transient elastography values in healthy South African children
by: Penelope C. Rose, et al.
Published: (2023-07-01)

DUSP9 alleviates hepatic ischemia/reperfusion injury by restraining both mitogen-activated protein kinase and IKK in an apoptosis signal-regulating kinase 1-dependent manner
by: Li Zhongtang, et al.
Published: (2022-12-01)

T cells and liver fibrosis
by: Ruonan Sun, et al.
Published: (2022-09-01)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
by: Li-ya Mu, et al.
Published: (2021-06-01)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
by: Yu-Ting Xiong, et al.
Published: (2023-02-01)

Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis
by: Xiaohua Li, et al.
Published: (2020-07-01)

Mechanistic Insight and Clinical Implications of Ischemia/Reperfusion Injury Post Liver TransplantationSummary
by: Jiang Liu, et al.
Published: (2023-01-01)

POSSIBLE WAYS OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC DAMAGE TO THE LIVER WITH THE AGONIST OF PERIPHERAL IMIDAZOLINE RECEPTORS C7070
by: Anton Dovgan, et al.
Published: (2017-09-01)

A non-human primate model of acute liver failure suitable for testing liver support systems
by: Ranjeet S. Kalsi, et al.
Published: (2022-09-01)

Autoimmune Hepatitis and Fibrosis
by: Rinaldo Pellicano, et al.
Published: (2023-03-01)

The role of p53 in liver fibrosis
by: Siyu Yu, et al.
Published: (2022-10-01)

Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
by: Tea Omanovic Kolaric, et al.
Published: (2023-05-01)

Effect of osteopontin in pathogenesis of hepatic ischemia-reperfusion injury of rats
by: GUO Liping, SU Juan, TIAN Xinyan, LU Li, HU Yarong, QIN Yan
Published: (2023-01-01)

Comparison of Liver Biopsy with Hepascore in Patients with Hepatitis C-Genotype 1
by: Hamid Klantari, et al.
Published: (2011-06-01)

Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl4-induced liver fibrosis
by: Kazuhiko Ikeuchi, et al.
Published: (2023-03-01)

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
by: In Ku Yo, et al.
Published: (2015-03-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Combating Ischemia-Reperfusion Injury with Micronutrients and Natural Compounds during Solid Organ Transplantation: Data of Clinical Trials and Lessons of Preclinical Findings
by: Christina Mauerhofer, et al.
Published: (2021-10-01)

Platelet Volume Indices as Non - Invasive Physiological Marker of Liver Fibrosis in Chronic Hepatitis C Patients
by: Yar Mohammad Nizamani, et al.
Published: (2017-06-01)

Mitophagy in the Pathogenesis of Liver Diseases
by: Po-Yuan Ke
Published: (2020-03-01)

Downregulation of Bmal1 Expression in Celiac Ganglia Protects against Hepatic Ischemia-Reperfusion Injury
by: Jiarui Feng, et al.
Published: (2023-04-01)

N-acetilcisteína diminui a congestão hepática na lesão de isquemia e reperfusão: estudo experimental
by: Eduardo Chaise Didoné, et al.

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapyResearch in context
by: Kasha P. Singh, et al.
Published: (2024-04-01)